-The Indian Express This, despite it being contract-manufactured by Pune’s Serum Institute of India whose CEO Adar Poonawalla had said that the firm was making a profit even at a price of Rs 150 per dose. At Rs 600 per dose, Indians getting inoculated with Covishield at private hospitals from May 1 could end up paying the highest price in the world for this Vaccine developed by the University of Oxford and...
More »SEARCH RESULT
New coronavirus cases cross 3.32 lakh in India with 2,247 more deaths on April 22, 2021
-The Hindu India accounts for 1 in 3 cases globally With 3,32,348 new COVID-19 cases as of 11.30 p.m. IST on April 22, India reported more than 3 lakh new infections for the second consecutive day. As many as 2,247 new deaths were also recorded. The country has so far reported a total of 1,62,57,337 cases and 1,86,919 deaths. The figures do not include cases and deaths from Ladakh. The data are sourced...
More »India’s decision to liberalise Vaccine sales likely to push up prices – and block access to millions -R Ramakumar
-Scroll.in Besides, by making states responsible for buying Vaccines, Modi’s government has deftly deflected possible criticism for future shortages. Over the past few weeks, the second wave of Covid-19 infections and the acute shortage of Vaccines had led to considerable public anger against the government. Despite being fully aware of a potential Vaccine shortage, the Union government had held back permissions for new Vaccines, such as the Sputnik V, to be used in...
More »Will You Ask Patients To Wait For Oxygen, Court Slams Centre -Arvind Gunasekar
-NDTV.com As the Delhi government said it had logged a record 32,000 cases in a single day yesterday, the High Court also raised questions on the Centre's distribution policy on oxygen and Vaccines. New Delhi: Taking up allegations of oxygen shortage and discrimination in resources leaving Delhi hamstrung in its Covid fight, the High Court said today if medicines were not being sent to places that really needed them, "blood is on...
More »The second wave questions that need urgent answers -Kaushik Das Gupta
-The Indian Express Is the government postponing the use of the Rs 35,000-crore allocated for Vaccine development in the current Budget? Has it been shy in using its good offices with the US to intercede on behalf of the country’s Vaccine manufacturing companies? This time, last year, India was under a lockdown announced by Prime Minister Narendra Modi in a televised address during which he issued several messages of caution. He talked...
More »